BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16613318)

  • 1. Prostate cancer diagnosis: even the experts disagree.
    Delahunt B
    Hum Pathol; 2006 Mar; 37(3):251-2. PubMed ID: 16613318
    [No Abstract]   [Full Text] [Related]  

  • 2. Broadsheet number 45: thin core biopsy of prostate. The Royal College of Pathologists of Australia.
    Delahunt B; Nacey JN
    Pathology; 1998 Aug; 30(3):247-56. PubMed ID: 9770188
    [No Abstract]   [Full Text] [Related]  

  • 3. A simple way to improve immunoreactivity of prostate needle biopsies fixed in Bouin's solution to AMACR.
    Ortiz-Rey JA; San Miguel-Fraile P; Gómez de María C; Huri de Lama S; Rodríguez Sánchez MC
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):280-2. PubMed ID: 22935828
    [No Abstract]   [Full Text] [Related]  

  • 4. In the diagnosis of limited prostate cancer, is observer variability an important consideration when compared with variability of patient outcome?
    Dalton L
    Am J Surg Pathol; 2010 Jul; 34(7):1071-2; author reply 1072. PubMed ID: 20495442
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens.
    Rogatsch H; Moser P; Volgger H; Horninger W; Bartsch G; Mikuz G; Mairinger T
    Hum Pathol; 2000 Sep; 31(9):1102-7. PubMed ID: 11014578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis.
    Elshafei A; Kartha G; Li Y; S Moussa A; Hatem A; Gao T; Jones JS
    Prostate; 2014 Sep; 74(12):1183-8. PubMed ID: 24962004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate biopsy: characteristics of the histological sample].
    De Matteis A; Bollito E; Galosi AB; Gardiman M; Montironi R; Sentinelli S;
    Arch Ital Urol Androl; 2005 Sep; 77(3 Suppl 1):28-32. PubMed ID: 16402727
    [No Abstract]   [Full Text] [Related]  

  • 8. Benign mimics of prostatic adenocarcinoma on needle biopsy.
    Gaudin PB; Reuter VE
    Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multi-core prostatic biopsy].
    Rodríguez Duarte C
    Arch Esp Urol; 2002 Oct; 55(8):907-14. PubMed ID: 12455281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies between findings suspicious for prostate cancer at rectal examination and benign biopsy findings.
    Epstein JI
    Radiology; 1993 Dec; 189(3):657-8. PubMed ID: 7694309
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy.
    Navarro M; Ruiz I; Martín G; Cruz JJ
    Prostate Cancer Prostatic Dis; 2006; 9(2):190-1. PubMed ID: 16331297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse p63 positivity in prostate cancer: a mimic of prostatic atrophy.
    Rao P; Dwyer M; Mikel J; Varma M
    Histopathology; 2012 Apr; 60(5):847-8. PubMed ID: 22260619
    [No Abstract]   [Full Text] [Related]  

  • 13. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens.
    Arista-Nasr J; Keirns C
    Am J Clin Pathol; 1998 Sep; 110(3):409. PubMed ID: 9728620
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenocarcinoma of the prostate simulating primary rectal malignancy.
    Olsen BS; Carlisle RW
    Cancer; 1970 Jan; 25(1):219-22. PubMed ID: 5410312
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer masquerading as a zygomatic posttraumatic mass.
    Harlan JW; Petty PM; Bostwick DG
    Mayo Clin Proc; 1997 Mar; 72(3):248-50. PubMed ID: 9070201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for rebiopsy.
    Van Horn BM
    Am J Clin Pathol; 1998 Sep; 110(3):408-9. PubMed ID: 9728619
    [No Abstract]   [Full Text] [Related]  

  • 17. Background, methods, and protocols for the histopathological diagnosis of prostate carcinoma.
    Delprado W
    Methods Mol Med; 2003; 81():181-97. PubMed ID: 12725121
    [No Abstract]   [Full Text] [Related]  

  • 18. [Low-stage prostatic adenocarcinoma and atypical lesions of the prostate].
    Maganto Pavón E; García González R; Ruiz Zárate C; Fernández González I; Fernández Fernández A; Vallejo Herrador J; Mateos Torres A; Escudero Barrilero A
    Arch Esp Urol; 1990; 43(9):967-70. PubMed ID: 1708979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate adenocarcinoma manifesting as generalized lymphadenopathy.
    Moura FM; Garcia LT; Castro LP; Ferrari TC
    Urol Oncol; 2006; 24(3):216-9. PubMed ID: 16678051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies.
    Van der Kwast TH; Evans A; Lockwood G; Tkachuk D; Bostwick DG; Epstein JI; Humphrey PA; Montironi R; Van Leenders GJ; Pihl CG; Neetens I; Kujala PM; Laurila M; Mazerolles C; Bubendorf L; Finelli A; Watson K; Srigley J
    Am J Surg Pathol; 2010 Feb; 34(2):169-77. PubMed ID: 20061936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.